Gaynor Richard
CIK 0001741284
Director
Filings
16
Latest May 22, 2026
Issuers covered
3
Showing
16 of 16
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 67% | +2.6% | +11.5% | +23.6% | -27.2% |
| 90 days | 2 | 50% | -18.8% | -18.8% | +13.3% | -50.9% |
| 180 days | 2 | 50% | -28.4% | -28.4% | +7.2% | -64.0% |
| 365 days | 2 | 50% | -7.8% | -7.8% | +46.3% | -61.8% |
Issuers
Companies where Gaynor Richard has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ALKS | Alkermes Plc. | 9 | May 22, 2026 |
| ZLAB | Zai Lab Ltd | 6 | Mar 19, 2026 |
| INFI | Infinity Pharmaceuticals, Inc. | 1 | Jun 16, 2022 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|